Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name SNHG3
   Synonyms SNHG3, NCRNA00014, RNU17C, RNU17D, U17HG, U17HG-A, U17HG-AB, NCRNA00014
   Region GRCh38_1:28505980-28510892    Sequence
   Ensembl ENSG00000242125
   RefSeq NR_002909.1
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name ovarian cancer
   ICD-0-3 C56.9  
   Methods qPCR, Western blot, etc.
   Sample ovarian tissues, cell lines (SKOV3, TOV-21G, OVCAR-3, IOSE80)
   Expression Pattern up-regulated
   Function Description

TCGA analysis showed lncRNA SNHG3 was not only related to ovarian cancer survival, but also energy metabolism. SNHG3 was related to energy metabolism by regulating miRNAs and EIF4AIII, and those molecules had target sites with PKM, PDHB, IDH2, and UQCRH in the glycolysis, Kreb's cycle, and oxidative phosphorylation (OXPHOS) pathways. Furthermore, SNHG3 might be associated with drug resistance. it can be forecasted boldly that SNHG3 functioned as efficient microRNA-186a sponges to inhibit hsa-miR-186a-5p acting on 3â??UTR of PDHB

   Pubmed ID 29921511
   Year 2018
   Title The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
   External Links
   Links for  SNHG3 GenBank       HGNC       lncrnadb       Noncode
   Links for  ovarian cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.